Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Saudi Production Cuts Give Short-Term Lift to U.S. Oil Stocks

By Dana Blankenhorn, InvestorPlace Contributor

Cutting production and shutting in wells has halted the fall in oil prices, and oil stocks. Money is now moving into the strongest of them, but the long-term future remains bleak.

Advanced Micro Devices Is a Curious Defensive Play

By Dana Blankenhorn, InvestorPlace Contributor

AMD's profits did not fall in March and aren't likely to fall much for the June quarter. This is one stock that can resist the coronavirus.

Thanks to Elon Musk, Tesla Stock Is in a Pricey Class of Its Own

By Dana Blankenhorn, InvestorPlace Contributor

Tesla's next act may involve a move to Texas and the Chinese electric battery supply chain. What should you do with TSLA stock?

Be Prepared to Lose Everything if You Bet on Carnival Stock

By Dana Blankenhorn, InvestorPlace Contributor

Carnival raised new debt, sold stock to the Saudis and cut staff to get through November. But a second coronavirus wave could sink it.

Co-Diagnostics Stock Is a Buy Ahead of and After Earnings

By Dana Blankenhorn, InvestorPlace Contributor

Co-Diagnostics stock has emerged as a big winner from Covid-19. Testing for novel viruses may make it a long-term winner in the new normal.

Load More